RossiAFaggianoPAmadoAE. Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. Int J Cardiol. 2012;158(1):163–164.
2.
TziomalosKAthyrosVGKaragiannisAMikhailidisDP. Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?Expert Opin Ther Targets. 2008;12(7):809–820.
KorkmazLAgacMTBektasH. Relation between aortic valve sclerosis and ankle-brachial index in participants clinically free of atherosclerotic vascular disease [published online December 23, 2012]. Angiology. 2012. doi:10.1177/0003319713475700
5.
IxJHShlipakMGKatzR. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2007;50(3):412–420.
6.
SkolnickAHOsranekMFormicaPKronzonI. Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol. 2009;104(1):122–124.
7.
ParolariALoardiCMussoniL. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiothorac Surg. 2009;35(3):493–504.
8.
DaviesMRLundRJMathewSHruskaKA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol JASN. 2005;16(4):917–928.
9.
SchonenbergerAWinkelspechtBKohlerHGirndtM. High prevalence of aortic valve alterations in haemodialysis patients is associated with signs of chronic inflammation. Nephron Clin Pract. 2004;96(2):c48–c55.
